- Home
- WYY vs BRNS Comparison
WYY vs BRNS Comparison
Compare WYY & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- BRNS
- Stock Information
- Founded
- WYY 1991
- BRNS 2016
- Country
- WYY United States
- BRNS United Kingdom
- Employees
- WYY N/A
- BRNS N/A
- Industry
- WYY EDP Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- BRNS Health Care
- Exchange
- WYY Nasdaq
- BRNS Nasdaq
- Market Cap
- WYY 35.6M
- BRNS 38.7M
- IPO Year
- WYY 1998
- BRNS 2021
- Fundamental
- Price
- WYY $3.01
- BRNS $1.08
- Analyst Decision
- WYY Strong Buy
- BRNS Strong Buy
- Analyst Count
- WYY 1
- BRNS 2
- Target Price
- WYY $7.00
- BRNS $3.00
- AVG Volume (30 Days)
- WYY 210.9K
- BRNS 53.8K
- Earning Date
- WYY 05-15-2025
- BRNS 05-07-2025
- Dividend Yield
- WYY N/A
- BRNS N/A
- EPS Growth
- WYY N/A
- BRNS N/A
- EPS
- WYY N/A
- BRNS N/A
- Revenue
- WYY $142,582,209.00
- BRNS $14,969,000.00
- Revenue This Year
- WYY $10.84
- BRNS N/A
- Revenue Next Year
- WYY $12.37
- BRNS N/A
- P/E Ratio
- WYY N/A
- BRNS N/A
- Revenue Growth
- WYY 24.03
- BRNS 4381.74
- 52 Week Low
- WYY $2.19
- BRNS $0.64
- 52 Week High
- WYY $6.25
- BRNS $2.14
- Technical
- Relative Strength Index (RSI)
- WYY 35.88
- BRNS 60.08
- Support Level
- WYY $2.90
- BRNS $0.65
- Resistance Level
- WYY $3.27
- BRNS $1.11
- Average True Range (ATR)
- WYY 0.49
- BRNS 0.13
- MACD
- WYY -0.22
- BRNS 0.02
- Stochastic Oscillator
- WYY 5.06
- BRNS 93.42
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.